Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 8/20 | 0.47 |
| ▸ | MAOB | P27338 | 8/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GLS | O94925 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL209838 | 0.87 | GLS (0.52) | HDAC1L3MBTL1GLS | |
| SCHEMBL29952891 | 0.87 | GLS (0.52) | HDAC1L3MBTL1GLS | |
| SCHEMBL596575 | 0.83 | HDAC1 (0.67) | HDAC1MAOBRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL26508626 | 0.81 | HDAC1 (0.56) | HDAC1L3MBTL1GLS | |
| SCHEMBL80390 | 0.80 | NAMPT (0.47) | HDAC1L3MBTL1GLS | |
| SCHEMBL17136480 | 0.80 | HDAC1 (0.65) | HDAC1ALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL208544 | 0.79 | EPHX2 (0.57) | HDAC1RAB9ANPC1TDP1L3MBTL1 | |
| SCHEMBL20132198 | 0.79 | SIRT2 (0.59) | HDAC1MAOAMAOBRAB9ANPC1 | |
| SCHEMBL26508246 | 0.78 | MAOA (0.56) | HDAC1MAOAMAOBRAB9ANPC1 | |
| SCHEMBL12188295 | 0.78 | MAOB (0.54) | HDAC1MAOAMAOBGID4SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1250317-B1 | BIS-BASIC COMPOUNDS FOR USE AS TRYPTASE INHIBITORS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-6780863-B1 | TREAT INFLAMMATORY AND/OR ALLERGIC CONDITIONS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-08-24 | — | — | US | disclosed |
| EP-1250317-A2 | BIS-BASIC COMPOUNDS FOR USE AS TRYPTASE INHIBITORS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim Pharma KG (DE) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001036374-A2 | BIS-BASIC COMPOUNDS FOR USE AS TRYPTASE INHIBITORS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-05-25 | — | — | WO | disclosed |